271 related articles for article (PubMed ID: 19497295)
1. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.
Vlasak J; Bussat MC; Wang S; Wagner-Rousset E; Schaefer M; Klinguer-Hamour C; Kirchmeier M; Corvaïa N; Ionescu R; Beck A
Anal Biochem; 2009 Sep; 392(2):145-54. PubMed ID: 19497295
[TBL] [Abstract][Full Text] [Related]
2. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
[TBL] [Abstract][Full Text] [Related]
3. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
4. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.
Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P
PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329
[TBL] [Abstract][Full Text] [Related]
6. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
7. HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region.
Boyd D; Kaschak T; Yan B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):955-60. PubMed ID: 21440514
[TBL] [Abstract][Full Text] [Related]
8. Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry.
Valliere-Douglass J; Jones L; Shpektor D; Kodama P; Wallace A; Balland A; Bailey R; Zhang Y
Anal Chem; 2008 May; 80(9):3168-74. PubMed ID: 18355059
[TBL] [Abstract][Full Text] [Related]
9. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A
J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547
[TBL] [Abstract][Full Text] [Related]
10. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
12. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
Terashima I; Koga A; Nagai H
Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
[TBL] [Abstract][Full Text] [Related]
14. Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein.
Zhang J; Yip H; Katta V
Anal Biochem; 2011 Mar; 410(2):234-43. PubMed ID: 21130067
[TBL] [Abstract][Full Text] [Related]
15. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody.
Dick LW; Qiu D; Cheng KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3841-9. PubMed ID: 19819766
[TBL] [Abstract][Full Text] [Related]
16. Structural changes induced by the deamidation and isomerization of asparagine revealed by the crystal structure of Ustilago sphaerogena ribonuclease U2B.
Noguchi S
Biopolymers; 2010 Nov; 93(11):1003-10. PubMed ID: 20623666
[TBL] [Abstract][Full Text] [Related]
17. Engineering an anti-CD52 antibody for enhanced deamidation stability.
Qiu H; Wei R; Jaworski J; Boudanova E; Hughes H; VanPatten S; Lund A; Day J; Zhou Y; McSherry T; Pan CQ; Sendak R
MAbs; 2019 Oct; 11(7):1266-1275. PubMed ID: 31199181
[TBL] [Abstract][Full Text] [Related]
18. Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rate.
Dick LW; Qiu D; Wong RB; Cheng KC
Biotechnol Bioeng; 2010 Feb; 105(3):515-23. PubMed ID: 19806678
[TBL] [Abstract][Full Text] [Related]
19. Probing deamidation in therapeutic immunoglobulin gamma (IgG1) by 'bottom-up' mass spectrometry with electron transfer dissociation.
Mukherjee R; Adhikary L; Khedkar A; Iyer H
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):879-84. PubMed ID: 20196189
[TBL] [Abstract][Full Text] [Related]
20. O-fucosylation of an antibody light chain: characterization of a modification occurring on an IgG1 molecule.
Valliere-Douglass JF; Brady LJ; Farnsworth C; Pace D; Balland A; Wallace A; Wang W; Treuheit MJ; Yan B
Glycobiology; 2009 Feb; 19(2):144-52. PubMed ID: 18952827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
